Update on Humira Biosimilars and Navitus' Standard Formularies

Humira Biosimilars Enter the Marketplace – Update on Navitus’ Review

The market entry of biosimilars to Humira® (adalimumab) is long-awaited. These products have the potential to improve affordability in the near- and...

Read More
News, Insider, Specialty
Five Forecasts for Plan Sponsors in 2023

Five Forecasts and Takeaways for Plan Sponsors in 2023

As we enter 2023, David Fields is sharing his top forecasts and takeaways for plan sponsors and the PBM industry.

Read More
News, Insider, Specialty

Building Specialty Pharmacy Success

Sharon Faust, PharmD, Vice President of Specialty Pharmacy for Lumicera shares a few key initiatives that will continue to create an impact for...

Read More
News, Specialty
2022 PBM trends for plan sponsors

2022 Pharmacy Benefit Predictions: What Plan Sponsors Should Watch

Navitus’ CEO, David Fields, shares his insights into the pharmacy benefits industry that will help plan sponsors achieve greater cost savings,...

Read More
Insider, Specialty

In the Pipeline: Specialty Drugs to Watch in 2022

Specialty medication development has grown rapidly, encompassing up to 80% of new FDA drug approvals in recent years. Read on to learn about the most...

Read More
Insider, Specialty
specialty drugs

[Webinar] How to Better Manage Specialty Drug Spend for Chronic Conditions

Didn’t have time to attend our recent webinar on managing chronic conditions? Don’t worry – we’ve got you covered with a recap!

Read More
Specialty, Webinars

Seize the Opportunity to Control Your Specialty Drug Spend

Provider-administered specialty drugs covered under the medical benefit can cost far more than their average wholesale price (AWP). As a result...

Read More
Insider, Specialty

Limited Distribution Drugs: What You May Not Know (rerun)

More than 75% of pharmaceutical manufacturers are choosing to limit the number of pharmacies that can dispense certain specialty medications.1 Find...

Read More
Insider, Specialty

In the Pipeline: Specialty Drugs to Watch in 2021

Despite the pandemic, manufacturers are continuing to develop new drugs, especially specialty medications. Read on for the most important specialty...

Read More
Insider, Specialty

Webinar: Lowering Costs & Improving Quality of Care for Chronic Populations

Recent data shows patients with chronic conditions are largely driving health care spending, yet many plans are seeing suboptimal outcomes. So, what...

Read More
Specialty, Webinars

Subscribe Here!

Content not found